Latest posts tagged with #ESSO44 on Bluesky
Presentation of the “2025 Multi-Societal European Guideline on #PancreaticCancer” recommendations
✅Today #ESSO44 🙌 #Gothenburg 🇸🇪
✅ Initiated by @eahpba.bsky.social #ESSO
✅ Coordinated by Laura Leeuwenburgh & Magdalena Holze @erangelova.bsky.social
⏩️ esso44.gcon.me/programme
The SSO was honored to attend the 44th ESSO Congress in Gothenburg, Sweden, and to engage with the esteemed leadership of @essonews.bsky.social.
We are proud to continue fostering international collaboration and innovation in surgical oncology through global engagement.
#ESSO44
Deeply honoured for participating in #ESSO44 Gothenburg as speaker in the session Progress in Pseudomyxoma Peritonei Therapy! @essonews.bsky.social
To Berlin now for an exciting #ESMO25 @myesmo.bsky.social #ESMODailyReporter
and shortly see you at PSOGI meeting in Barcelona
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Isabel Rubio
De-Escalate Staging and Management of the Axilla Recurrent Breast Cancer
Isolated axillary recurrence after prior #BreastCancer treatment presents a complex management challenge, balancing oncologic control with morbidity.
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Philipp Lennartsson 🇸🇪
Best Swedish Abstracts: The Role of Tumor Location in Pancreatic Cancer on Perioperative Outcome and Long-Term Survival
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Localisation and Resection of #Melanoma Metastases
This presentation addresses strategies for detecting metastatic disease following neoadjuvant therapy
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala🇸🇪
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma to the Live
Examines the use of percutaneous hepatic perfusion for the treatment of metastatic uveal #melanoma to the liver
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Oliver Gimm 🇸🇪
Updates on Partial Adrenalectomy for Medullary and Cortical Adrenal Tumours
Partial adrenalectomy serves primarily to preserve adrenal function in patients with bilateral adrenal disease.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Markus Mille 🇩🇪
Discussing: Robotic Single Port SP Surgery
Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Stefan Stättner 🇦🇹
Discussing Robotic Liver Surgery
Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Wim Ceelen 🇧🇪 Ghent
Physically Enhanced IP Drug Delivery
Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. I discuss how physical methods overcome transport barriers.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Øyvind Bruland 🇳🇴 Oslo
Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Lasma Nikolaisone 🇱🇻
The Testimonial of a Young Rectal Cancer Patient
Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly #RectalCancer
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Laura Lorenzon 🇮🇹
Investigation and Management of GI Symptoms After Surgery
This presentation highlights the main dimensions related to quality of life, the main metrics used to measure symptoms and the main issues in this field
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Melanoma Staging and Molecular Testing
Presentation reviews current AJCC staging system for melanoma, outline present state of staging practices, and explore potential areas for refinement
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Anders Thornell 🇸🇪 Sahlgrenska
Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated?
Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and guideline evolution.
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Elinor Bexe Lindskog 🇸🇪
The Immune Microenvironment in Peritoneal Metastases
The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory, immune-regulated niche
